Esperion Therapeutics Inc (ESPR)
Operating Cash Flow Growth
81.83%
TTM · Period ending:
ESPR Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported81.83%period ending
Latest reported81.83%period ending
ESPR TTM Cash from Operations YoY % (-26.81% → 81.83%)
Year-over-year change
High-resolution chart · PNG
ESPR operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 81.833% | |
| 44.6478% | |
| -262.171% | |
| -1,174.1033% | |
| -266.663% | |
| 82.5415% | |
| 81.6909% | |
| 94.0649% | |
| 85.6446% | |
| 22.5022% | |
| 26.0647% | |
| 24.0234% | |
| 11.0129% | |
| 33.7297% | |
| 30.7199% | |
| 25.9308% | |
| -103.7513% | |
| -209.7186% | |
| -312.2619% | |
| -669.2541% | |
| 54.664% | |
| -21.0915% | |
| -35.8531% | |
| -33.0869% | |
| -1,585.6987% | |
| 52.6763% | |
| 68.3252% | |
| 81.3699% | |
| 90.2102% | |
| -13.2031% | |
| -37.3199% | |
| -68.0236% | |
| -94.0769% | |
| -175.0932% | |
| -182.8287% | |
| -143.8257% | |
| -86.6937% | |
| -25.0917% | |
| -5.1378% | |
| -7.6996% | |
| -20.2486% | |
| -19.1593% | |
| -20.9667% | |
| -26.2894% | |
| -30.862% | |
| -76.7811% | |
| -141.981% | |
| -148.0512% | |
| -128.7594% | |
| -67.5834% | |
| 16.9785% | |
| 41.0044% | |
| 53.0819% | |
| 4.2323% | |
| 0.7086% | |
| -7.7712% | |
| -16.6776% | |
| -20.0578% | |
| -24.2836% | |
| -26.9695% | |
| -26.8074% |